chrysophanic acid has been researched along with Angioblastic Meningioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, P; Wang, J | 1 |
| Chen, J; Guo, B; He, W; Zeng, C | 1 |
2 other study(ies) available for chrysophanic acid and Angioblastic Meningioma
| Article | Year |
|---|---|
Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells.
Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Intercellular Signaling Peptides and Proteins; Meningeal Neoplasms; Meningioma; Neurofibromin 2; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Antitumor Effects of Chrysophanol in Malignant Optic Nerve Meningioma Cell Lines are Mediated via Caspase Activation, Induction of Mitochondrial Mediated Apoptosis, Mitochondrial Membrane Depolarization and Targeting the Mitogen-Activated Protein Kinase S
Topics: Anthraquinones; Apoptosis; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Meningeal Neoplasms; Meningioma; Mitochondrial Membranes; Optic Nerve Neoplasms | 2019 |